NEW HOPE FOR MILLIONS OF ASTHMA SUFFERERS

MUSSEL OIL IN LYPRINOL SLASHES DEPENDENCE ON INHALERS BY 83%

AN oil discovered in New Zealand mussels by British scientists in the 1980s could offer new hope to millions of asthma sufferers around the world, according to groundbreaking new research.

The study, led by Professor Timothy D. Mickleborough at Indiana University, found that the oil from New Zealand mussels – found only in Lyprinol – reduced dependence on inhalers by a staggering 83 per cent and improved the lung function of asthmatics who suffer from exercise-induced attacks by 59 per cent.

The oil, called PCSO-524, was first discovered by Dr Sheila Gibson and used to treat arthritis-related inflammation at Glasgow’s Victoria Infirmary in 1980. Today, Lyprinol is commonly used to support joint health and reduce inflammation related to conditions including arthritis. It is the only product available that contains PCSO-524.

Prof Mickleborough said:
“These findings are a real breakthrough, and offer new hope for asthma sufferers all over the world. Reducing the dependence on inhalers will offer those who suffer from asthma a new freedom, while the ability to lower the risk of exercise-induced asthma attacks will allow sufferers to increase their health and pursue their athletic ambitions more freely.

“We already know the benefits of Lyprinol in joint health and inflammation, but this new study indicates that this supplement- and the mussel oil PCSO-524 offers more health-giving potential than we previously thought. It’s a hugely exciting time.”

Prof Mickleborough’s study will be published in a forthcoming issue of the peer-reviewed British journal, Respiratory Medicine. It is also available online: http://bit.ly/10oZJEk